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Abstract DNA methylation occurs at CpG dinucleotide
sites within the genome and is recognised as one of the
mechanisms involved in regulation of gene expression.
CpG sites are relatively underrepresented in the mamma-
lian genome, but occur densely in regions called CpG
islands (CGIs). CGIs located in the promoters of genes
inhibit transcription when methylated by impeding tran-
scription factor binding. Due to the malleable nature of
DNA methylation, environmental factors are able to
inﬂuence promoter CGI methylation patterns and thus
inﬂuence gene expression. Recent studies have provided
evidence that nutrition (and other environmental expo-
sures) can cause altered CGI methylation but, with a few
exceptions, the genes inﬂuenced by these exposures remain
largely unknown. Here we describe a novel bioinformatics
approach for the analysis of gene expression microarray
data designed to identify regulatory sites within promoters
of differentially expressed genes that may be inﬂuenced by
changes in DNA methylation.
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Introduction
DNA is methylated by the covalent addition of methyl
groups to the 50 position on cytosine residues, usually when
the cytosine is followed by a guanine residue—i.e. in a
CpG dinucleotide. Although CpG dinucleotides are under-
represented in the genome, there are dense accumulations
of CpGs (CpG islands; CGI) in the promoter regions of
many genes. When CpG dinucleotides in CGI located near
the transcription start site of a gene are methylated, this is
usually associated with gene repression. Other epigenetic
marks, especially post-translational modiﬁcations of his-
tone tails, also contribute to regulation of gene expression.
Therefore the pattern of CpG methylation impacts upon
phenotype by altering gene expression. For example, in the
agouti mouse methylation of speciﬁc CpG sites within the
intra-cisternal A particle (IAP) region of the Agouti gene
can inﬂuence coat colour, body weight and longevity [20].
Aberrant DNA methylation is associated with several dis-
eases, e.g. cancer, occurs during ageing and has been
implicated as one possible mechanism involved in the
developmental origins of adult health and disease.
The main patterns of DNA methylation are established
during early embryonic and fetal life, but methylation
marks are plastic and can be inﬂuenced by environmental
factors especially when these factors are applied during
development [4, 10, 11, 16, 20–22]. Although most
research to date has been carried out using animal models,
it is likely that environmental factors also inﬂuence
DNA methylation, and therefore phenotype, in humans. In
patients with hyper-homocysteinaemia, genomic DNA
methylation is lower than that in controls [7]. Hyper-
homocysteinaemia is characterised by increased cellular
concentrations of S-adenosylhomocysteine (SAH), which is
an inhibitor of DNA methyltransferase 1 (DNMT1)—the
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Supplementing the diet of such patients with folate, which
provides methyl groups for the synthesis of S-adenosyl-
methionine (SAM; the universal methyl donor) and alters
the SAM:SAH ratio, restored genomic DNA levels to
normal and also ‘corrected’ CpG methylation within the
IGF2-H19 locus [7].
A large proportion (70–80%) of global DNA methyla-
tion occurs in non-coding regions, exons and repetitive
DNA sites within the genome [8] and little is known about
the functional consequences of changes in genomic DNA
methylation. In contrast, methylation at speciﬁc CpG sites
in or around the promoter regions of genes can inﬂuence
transcription so it is imperative to understand which loci
within the genome are susceptible to environmentally-
determined modiﬁcation of DNA methylation patterns. A
candidate gene approach has been used successfully in
studies of cancer aetiology and pathophysiology, where it
is reasonable to predict that targets would include tumour
suppressor genes since their silencing is of obvious aetio-
logical signiﬁcance. Such an approach is likely to be less
successful for other complex diseases where potential
candidate genes are less readily identiﬁed. A candidate
gene approach is also less appropriate in the context of
(relatively mild) nutritional exposures, where the effects on
gene expression may be small and widespread across the
genome. In addition, since dietary factors can inﬂuence
gene expression by several other mechanisms [12], the
relationship between changes in gene expression and cor-
responding changes in DNA methylation patterns are
difﬁcult to decipher. To help address this problem, we have
developed a novel strategy to identify target loci that have
shown differential gene expression in response to nutri-
tional exposure, which potentially could be due to altered
DNA methylation. To do so, we used a mouse model in
which dams were fed a folate deplete diet prior to and
during pregnancy, and investigated the effects of folate
depletion in utero on fetal liver gene expression at
17.5 days’ gestation. In this paper we outline our strategy
and describe how we have used bioinformatic tools to
analyse these gene expression array data to identify regu-
latory sites within promoters of differentially expressed
genes that could potentially be inﬂuenced by differential
DNA methylation.
Strategy
Figure 1 provides an overview of the strategy employed
to ﬁnd gene targets with possible aberrant methylation.
Firstly, to identify target genes, microarray data were
analysed to identify a list of differentially expressed
genes. We used the automatic transcriptomics analysis
pipeline that was developed by NuGO (the European
Nutrigenomics Organisation) and that is accessible from
the NuGO Blackboxes through Genepattern. The pipeline
employs several packages from the Bioconductor project
(http://www.bioconductor.org) and includes procedures
for quality control, normalisation and statistical analysis
of microarray data. The resulting annotated gene list was
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Fig. 1 Overview of strategy developed to identify target genes whose
expression may have been altered by DNA methylation aberrations.
Genepattern can be accessed through any NuGO Blackbox (NBX).
Web address for bioinformatics tools are as follows: Genomatix;
http://www.genomatix.de, CpG Island Explorer; http://bioinfo.hku.
hk/cpgieintro.html
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with altered expression. As (relatively mild) nutritional
exposures are likely to lead to subtle changes in gene
expression when compared with pharmaceutical inter-
ventions, we routinely ﬁlter for genes with a 20% change
in expression, i.e. either above 1.2 or below -1.2. As we
are interested only in genes for which the changes in
expression are statistically signiﬁcant, we ﬁlter using a
threshold of P = 0.05. P values were corrected for mul-
tiple testing using the Benjamini and Hochberg [1]
approach. From this analysis we obtained a list of genes
showing signiﬁcant differential expression. By mapping
these genes to pathways, it was possible to ﬁlter the list
further by selecting only those genes occurring in path-
ways of interest, i.e. those pathways plausibly linked
biologically to the processes being considered. Examples
of useful pathway tools are Pathvisio [18], GenMAPP
[15] and GeneGO’s Metacore [5]. Pathway analysis can
only be as good as the pathway information used. To
allow evaluation of gene expression changes in processes
directly related to DNA methylation we created a one-
carbon metabolism pathway on WikiPathways [13] and
used that in PathVisio and GenMAPP.
The next stage was to identify the promoter sequences of
the selected genes. The promoter is the site responsible for
regulation of gene transcription and houses several regula-
tory DNA motifs including transcription factor binding sites
(TFBS) and, in many cases, CGI. Characterising the pro-
moter is therefore essential to understand the regulatory
networks responsible for differential gene expression. Pro-
moter identiﬁcation within genomic sequences can be
difﬁcult, although there are bioinformatic tools that can be
used to predict mammalian promoters (reviewed in [24]).
To be sure that a predicted promoter is indeed a promoter
requires wet-lab veriﬁcation. We use the validated promoter
database of the commercially available Genomatix software
(http://www.genomatix.de). Promoter sequences in this
database are scored as gold (experimentally veriﬁed 50
complete transcript), silver (transcript with 50 end conﬁrmed
by PromoterInspector prediction) or bronze (annotated
transcript, no conﬁrmation for 50 completeness) and this
scoring system can be used to eliminate less likely candi-
dates. At this stage, one may choose to leave out promoters
with less relevant transcripts, e.g. those where the func-
tional role of the gene product is unknown.
CpG sites are relatively under-represented in the mam-
malian genome but occur in unusually dense groupings in
CGI. These are areas of the genome between 0.5 and 4 kb
in length, with[50% GC content and an observed/expec-
ted CpG ratio of over 0.6. In the human genome, roughly
half of all genes contain CpG islands. CpG sites within
CpG islands tend to be largely unmethylated in normal
tissues. Furthermore, hypermethylation of CpG islands
within promoters of tumour suppressor genes is observed
commonly in tumour cells [6]. Therefore, we used presence
of a CGI as one criterion in our strategy to identify
potential target genes that may have been regulated by
DNA methylation.
There are several freely available web based tools,
such as MethPrimer (http://www.urogene.org/methprimer/
index1.html)[ 9] that can predict the presence of a CGI
within a given sequence. However, most of these tools can
analyse only one sequence at a time. Given that the list of
candidate genes arising from array data can be quite large,
even after ﬁltering at the pathway level, this approach is
unnecessarily laborious and time consuming. This problem
can be addressed by using CpG Island Explorer (http://
bioinfo.hku.hk/cpgieintro.html)[ 19], which is freely
available for download and is able to predict the presence
of CGI in multiple sequences simultaneously. It is based on
the algorithm and Perl script created by Takai and Jones
[17], which is still considered as the gold standard in CpG
island searching.
Identiﬁcation of methylation-sensitive TFBS
Hypermethylation of CGI is associated with gene silencing
and this is generally associated with a ‘closed’ chromatin
structure that reduces access of transcription factors and
other transcriptional machinery to the DNA. However, it is
also known that methylation of single speciﬁc CpG sites
can be associated with decreased expression of some genes
[2, 14]. In some cases, methylation of these speciﬁc sites
prevents binding of transcription factors essential for gene
expression. Therefore part of our strategy to identify genes
whose expression may be altered due to DNA methylation
changes was to search for the presence of CpG sites within
TFBS of promoters.
Promoter function is governed by the binding of tran-
scription factors to the DNA sequence. An isolated TFBS is
often not functional. Werner [23] argued that TFBS act in a
modular fashion allowing the support of protein complexes
for transcriptional activation. His deﬁnition of a tran-
scription factor (TF) module is ‘two or more transcription
factor binding sites in a deﬁned order and orientation that
comprise promoter modules’. If one TFBS within a module
is functionally impaired, by a point mutation in the DNA
sequence or due to methylation of a CpG site within the
binding site, this causes the complete TF module to be
inactivated.
We employed Genomatix software, speciﬁcally MatIn-
spector, to investigate TFBS within promoters since this
software is optimized for searching for matrices of TFBS
within sequences [3]. Further analysis of the resultant TF
module data list was used to identify modules with TFBS
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ules we identiﬁed common TF modules that occurred
regularly in our data set. Promoters containing common
modules in which TFBS have CpG sites are potential targets
for altered DNA methylation in response to a dietary (or
other environmental) exposure since it is likely that these
genes are regulated by a common mechanism. However, it
is important to be aware that it is also likely that the TFs
common to these modules could themselves be the cause of
altered expression of these genes. One potential way to
resolve this issue is to check the original array expression
data for changes in expression of the TF in question. If the
TF do not display differential expression, then it is more
likely that the observed changes in gene expression are due
to altered CpG methylation within TFBS.
Summary
We have developed a novel in silico strategy to identify
target genes that could potentially be regulated by DNA
methylation in response to a dietary (or other) exposure.
This strategy utilises the expression data from whole
genome transcriptomics arrays together with a compre-
hensive bioinformatics workﬂow to narrow the list of
gene targets for DNA methylation analysis. This strategy
is powerful and attractive in identifying genes that are
susceptible to DNA methylation changes, and therefore
may be of particular utility in pinpointing common genes
susceptible to aberrant DNA methylation using different
array datasets from a range of studies. With this approach,
it may be possible to identify speciﬁc DNA motifs that
are susceptible to aberrant DNA methylation in response
to environmental (nutritional) factors.
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